Antiretroviral regimen and suboptimal medication adherence are associated with low-level human immunodeficiency virus viremia

39Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Episodes of human immunodeficiency virus low-level viremia (LLV) are common in the clinical setting, but its association with antiretroviral therapy (ART) regimen and adherence remains unclear. Antiretroviral therapy adherence was evaluated in participants of the Research on Access to Care in the Homeless cohort by unannounced pill counts. Factors associated with increased risk of LLV include treatment with a protease inhibitor (PI)-based regimen (ritonavir-boosted PI vs nonnucleoside reverse-transcriptase inhibitor: adjusted hazard ratio [HR], 3.1; P = .01) and lower ART adherence over the past 3 months (HR, 1.1 per 5% decreased adherence, adjusted; P = .050). Patients with LLV may benefit fromART adherence counseling and potentially regimen modification.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Konstantopoulos, C., Ribaudo, H., Ragland, K., Bangsberg, D. R., & Li, J. Z. (2015). Antiretroviral regimen and suboptimal medication adherence are associated with low-level human immunodeficiency virus viremia. Open Forum Infectious Diseases, 2(1). https://doi.org/10.1093/ofid/ofu119

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 11

50%

Researcher 7

32%

Professor / Associate Prof. 3

14%

Lecturer / Post doc 1

5%

Readers' Discipline

Tooltip

Medicine and Dentistry 12

55%

Pharmacology, Toxicology and Pharmaceut... 4

18%

Nursing and Health Professions 3

14%

Agricultural and Biological Sciences 3

14%

Save time finding and organizing research with Mendeley

Sign up for free